Yahoo Web Search

Search results

    • Tango terminates USP1 inhibitor programme

      Tango terminates USP1 inhibitor programme

      Clinical Trials Arena via Yahoo Finance· 6 days ago

      Tango also planned to evaluate its therapy in combination with AstraZeneca’s and Merck & Co’s poly-ADP ribose polymerase (PARP) inhibitor Lynparza...